Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication that potentiates the effects of gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia
* Seizure management (e.g., status epilepticus)
* Premedication for medical procedures
* Management of agitation and delirium tremens
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally two to three times daily. Maximum: 10 mg/day.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV/IM, may repeat in 5 to 10 minutes. Maximum: 8 mg.
* **Premedication:** 2 mg to 4 mg orally or IM 2 hours before procedure, or 1 mg to 2 mg IV 15-30 minutes before procedure.
Dosing is highly individualized and should be titrated to the lowest effective dose.
## Pediatric Dosing
* **Anxiety:** Limited data. Dosing is typically lower than adults and requires careful titration. Oral doses of 0.02 mg/kg to 0.03 mg/kg every 8 hours have been used, not to exceed adult doses.
* **Seizures:** IV/IM doses of 0.1 mg/kg have been used, not to exceed 4 mg per dose.
Specific pediatric dosing should be guided by expert consultation or specialized pediatric protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dosage reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is usually required, but use with caution in severe impairment.
* **Elderly:** Start with lower doses (e.g., half of the usual adult starting dose) and titrate cautiously due to increased sensitivity to CNS effects and increased risk of falls.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
## Adverse Effects
* **Common:** Drowsiness, dizziness, sedation, unsteadiness, fatigue, weakness, ataxia.
* **Serious:** Respiratory depression, paradoxical reactions (e.g., excitation, aggression), dependence, withdrawal symptoms, amnesia.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
Use of lorazepam with opioids requires extreme caution and consideration of naloxone availability and monitoring for respiratory depression and sedation.
## Monitoring
* Respiratory rate, depth, and pattern.
* Level of consciousness and sedation.
* Blood pressure and heart rate.
* Signs of dependence or withdrawal, especially with long-term use or abrupt discontinuation.
* Effectiveness for the intended indication.
## Clinical Pearls
* Lorazepam is available in oral, sublingual, intramuscular, and intravenous formulations.
* Intramuscular injection is well-absorbed. Intravenous administration should be slow to minimize risk of hypotension and respiratory depression.
* Avoid abrupt discontinuation; taper dose gradually to prevent withdrawal symptoms.
* Consider potential for abuse and dependence, especially in patients with a history of substance abuse.
* Use with caution in elderly patients and those with pre-existing respiratory conditions.
***
**Disclaimer:** This information is intended for clinical use and is not exhaustive. Always consult the most current prescribing information, institutional protocols, and relevant literature before making clinical decisions.
